Jose Alejandro Bohorquez Garzon

Dr. Jose Alejandro Bohorquez Garzon

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
FYFan Yang
Fan Yang
ALAlireza Labani-Motlagh
Alireza Labani-Motlagh
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
JMJosimar Dornelas Moreira
Josimar Dornelas Moreira
DADanish Ansari
Danish Ansari
GYGuohua Yi
Guohua Yi
The continuing emergence of new strains of antibiotic-resistant bacteria has renewed interest in phage therapy; however, there has been limited progress in applying phage therapy to multi-drug resistant Mycobacterium tuberculosis (Mtb) infections. In this study, we show that bacteriophage strains D29 and DS6A can efficiently lyse Mtb H37Rv in 7H10 agar plates. However, only phage DS6A efficiently kills H37Rv in liquid culture and in Mtb-infected human primary macrophages. We further show in subsequent experiments that, after the humanized mice were infected with aerosolized H37Rv, then treated with DS6A intravenously, the DS6A treated mice showed increased body weight and improved pulmonary function relative to control mice. Furthermore, DS6A reduces Mtb load in mouse organs with greater efficacy in the spleen. These results demonstrate the feasibility of developing phage therapy as an effective therapeutic against Mtb infection.

21 September 2017 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
SMSara Muñoz-González
Sara Muñoz-González
ACA. Canturri
A. Canturri
MPM. Pérez-Simó
M. Pérez-Simó
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
RRR. Rosell
R. Rosell
Llilianne GangesLlilianne Ganges
Llilianne Ganges

9 July 2015 in Veterinary Research
Verified
Journal Article
Open access
PDF file
SMSara Muñoz-González
Sara Muñoz-González
MPMarta Perez-Simó
Marta Perez-Simó
MMMarta Muñoz
Marta Muñoz
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
RRRosa Rosell
Rosa Rosell
Llilianne GangesLlilianne Ganges
Llilianne Ganges
Classical swine fever (CSF) causes major losses in pig farming, with various degrees of disease severity. Efficient live attenuated vaccines against classical swine fever virus (CSFV) are used routinely in endemic countries. However, despite intensive vaccination programs in these areas for more than 20 years, CSF has not been eradicated. Molecular epidemiology studies in these regions suggests that the virus circulating in the field has evolved under the positive selection pressure exerted by the immune response to the vaccine, leading to new attenuated viral variants. Recent work by our group demonstrated that a high proportion of persistently infected piglets can be generated by early postnatal infection with low and moderately virulent CSFV strains. Here, we studied the immune response to a hog cholera lapinised virus vaccine (HCLV), C-strain, in six-week-old persistently infected pigs following post-natal infection. CSFV-negative pigs were vaccinated as controls. The humoral and interferon gamma responses as well as the CSFV RNA loads were monitored for 21 days post-vaccination. No vaccine viral RNA was detected in the serum samples and tonsils from CSFV postnatally persistently infected pigs for 21 days post-vaccination. Furthermore, no E2-specific antibody response or neutralising antibody titres were shown in CSFV persistently infected vaccinated animals. Likewise, no of IFN-gamma producing cell response against CSFV or PHA was observed. To our knowledge, this is the first report demonstrating the absence of a response to vaccination in CSFV persistently infected pigs.

15 July 2019 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
LCLiani Coronado
Liani Coronado
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
SMSara Muñoz-González
Sara Muñoz-González
LPLester J. Pérez
Lester J. Pérez
RRRosa Rosell
Rosa Rosell
Llilianne GangesLlilianne Ganges
Llilianne Ganges
Recent studies have hypothesized that circulation of classical swine fever virus (CSFV) variants when the immunity induced by the vaccine is not sterilizing might favour viral persistence. Likewise, in addition to congenital viral persistence, CSFV has also been proven to generate postnatal viral persistence. Under experimental conditions, postnatal persistently infected pigs were unable to elicit a specific immune response to a CSFV live attenuated vaccine via the mechanism known as superinfection exclusion (SIE). Here, we study whether subclinical forms of classical swine fever (CSF) may be present in a conventional farm in an endemic country and evaluate vaccine efficacy under these types of infections in field conditions. Six litters born from CSF-vaccinated gilts were randomly chosen from a commercial Cuban farm at 33 days of age (weaning). At this time, the piglets were vaccinated with a lapinized live attenuated CSFV C-strain vaccine. Virological and immunological analyses were performed before and after vaccination. The piglets were clinically healthy at weaning; however, 82% were viraemic, and the rectal swabs in most of the remaining 18% were positive. Only five piglets from one litter showed a specific antibody response. The tonsils and rectal swabs of five sows were CSFV positive, and only one of the sows showed an antibody response. After vaccination, 98% of the piglets were unable to clear the virus and to seroconvert, and some of the piglets showed polyarthritis and wasting after 36 days post vaccination. The CSFV E2 glycoprotein sequences recovered from one pig per litter were the same. The amino acid positions 72(R), 20(L) and 195(N) of E2 were identified in silico as positions associated with adaptive advantage. Circulation of chronic and persistent CSF infections was demonstrated in field conditions under a vaccination programme. Persistent infection was predominant. Here, we provide evidence that, in field conditions, subclinical infections are not detected by clinical diagnosis and, despite being infected with CSFV, the animals are vaccinated, rather than diagnosed and eliminated. These animals are refractory to vaccination, likely due to the SIE phenomenon. Improvement of vaccination strategies and diagnosis of subclinical forms of CSF is imperative for CSF eradication.

26 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMSara Muñoz-González
Sara Muñoz-González
MPMarta Pérez-Simó
Marta Pérez-Simó
ACAndreu Colom-Cadena
Andreu Colom-Cadena
OCOscar Cabezon
Oscar Cabezon
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
Llilianne GangesLlilianne Ganges
Llilianne Ganges
Two groups with three wild boars each were used: Group A (animals 1 to 3) served as the control, and Group B (animals 4 to 6) was postnatally persistently infected with the Cat01 strain of CSFV (primary virus). The animals, six weeks old and clinically healthy, were inoculated with the virulent strain Margarita (secondary virus). For exclusive detection of the Margarita strain, a specific qRT-PCR assay was designed, which proved not to have cross-reactivity with the Cat01 strain. The wild boars persistently infected with CSFV were protected from superinfection by the virulent CSFV Margarita strain, as evidenced by the absence of clinical signs and the absence of Margarita RNA detection in serum, swabs and tissue samples. Additionally, in PBMCs, a well-known target for CSFV viral replication, only the primary infecting virus RNA (Cat01 strain) could be detected, even after the isolation in ST cells, demonstrating SIE at the tissue level in vivo. Furthermore, the data analysis of the Margarita qRT-PCR, by means of calculated ΔCt values, supported that PBMCs from persistently infected animals were substantially protected from superinfection after in vitro inoculation with the Margarita virus strain, while this virus was able to infect naive PBMCs efficiently. In parallel, IFN-α values were undetectable in the sera from animals in Group B after inoculation with the CSFV Margarita strain. Furthermore, these animals were unable to elicit adaptive humoral (no E2-specific or neutralising antibodies) or cellular immune responses (in terms of IFN-γ-producing cells) after inoculation with the second virus. Finally, a sequence analysis could not detect CSFV Margarita RNA in the samples tested from Group B. Our results suggested that the SIE phenomenon might be involved in the evolution and phylogeny of the virus, as well as in CSFV control by vaccination. To the best of our knowledge, this study was one of the first showing efficient suppression of superinfection in animals, especially in the absence of IFN-α, which might be associated with the lack of innate immune mechanisms.

10 November 2018 in Veterinary Record
Verified
Journal Article
Closed access
PDF file
ACAndreu Colom‐Cadena
Andreu Colom‐Cadena
Llilianne GangesLlilianne Ganges
Llilianne Ganges
SMSara Muñoz-González
Sara Muñoz-González
RCRaquel Castillo-Contreras
Raquel Castillo-Contreras
JGJose Alejandro Bohorquez Garzon
Jose Alejandro Bohorquez Garzon
OCOscar Cabezon
Oscar Cabezon
Atypical porcine pestivirus (APPV) is a recently discovered putative species of the Pestivirus genus (Family Flaviviridae). Its genome has approximately 25–28 per cent pairwise identity to known pestiviruses and a 68 per cent pairwise identity to a recently characterised Rhinolophus affinis pestivirus, placing both viruses in a highly divergent lineage of pestiviruses. Since APPV was described in the USA in 2015,1 it has been found in pigs from Austria,2 China,3 England,4 Germany,5 6 the Netherlands,7 Spain8 and Sweden.9 Some of these studies also demonstrated the relationship of APPV to pigs displaying congenital tremor (CT) type AII.4 5 7 10 Recently, APPV was detected in wild boars from Germany and the Republic of Serbia.11 Muñoz-González et al 8 showed that APPV was present at least since 1997 in pigs from north-eastern Spain. In the same Spanish region where this ‘atypical’ pestivirus appears to be widely distributed, the European wild boar population is increasing and reaching high densities, as it is occurring throughout the European Basin.12 As the epidemiological role of wild pig in some domestic pig viral diseases is well known,13 the aim of the present study was to evaluate the presence of the recently described APPV in a European wild boar population. Sera from 437 wild boars were included in the study. The samples were collected during the hunting season from 2012 to 2016 in the …